CD4 and neoplasm: Average tumor volume growth after treatment indicated mice vaccinated with PancVAX2 experienced a significant decrease in average tumor volume compared with mice treated with PBS, CD4 vaccine, or CD8 vaccine (Figure 3, B and C).